Dual blockade of EGFR and VEGFR pathways: Results from a pilot study evaluating apatinib plus gefitinib as a first-line treatment for advanced EGFR-mutant non-small cell lung cancer
| Image |  |
|---|---|
| Description | scientific article published on 04 June 2020 |
| Author/s |
author: Wenfeng Fang Zhonghan Zhang Yan Huang |
| Publication date | June 4, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |